Evidence map›Paper›PMID 38194107›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2024

Evaluation of the protective effect of losartan in acetaminophen-induced liver and kidney damage in mice.

Serkan Şahin, Ayça Çakmak Aydın, Ayşe Yeşim Göçmen, Emin Kaymak

Open access · hybridAbstract read
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Serkan ŞahinDepartment of Medical Pharmacology, Faculty of Medicine, Yozgat Bozok University, Yozgat, Turkey. serkan.sahin@bozok.edu.tr.ORCID http://orcid.org/0000-0001-7000-6342
Ayça Çakmak AydınDepartment of Medical Pharmacology, Faculty of Medicine, Yozgat Bozok University, Yozgat, Turkey.
Ayşe Yeşim GöçmenDepartment of Biochemistry, Faculty of Medicine, Yozgat Bozok University, Yozgat, Turkey.
Emin KaymakDepartment of Histology, Faculty of Medicine, Yozgat Bozok University, Yozgat, Turkey.
Yozgat Bozok Üniversitesi · TR

Funding

Yozgat Bozok University Scientific Research Projects Unit 6602c-TF/21-437
6 · The paper itself

Abstract

Acetaminophen is widely used among humans as an antipyretic and analgesic. In this study, the protective effect of losartan in hepatotoxicity and nephrotoxicity induced by acetaminophen in mice was investigated owing to its anti-inflammatory and antioxidant effects. An injection of a single dose of 500 mg/kg (i.p.) acetaminophen was administered to induce hepatotoxicity and nephrotoxicity in Groups VI-X. Losartan at doses of 1 mg/kg (Group VII), 3 mg/kg (Group VIII), and 10 mg/kg (Groups III, V, IX, and X) was injected intraperitoneally twice, at 1 and 12 h after the acetaminophen injection. Additionally, a 4 mg/kg dose of GW9662 (peroxisome proliferator-activated receptor gamma (PPAR-γ) antagonist) was injected intraperitoneally 30 min before the losartan injections in Groups V and X. At the end of 24 h, the mice were euthanized, and blood, liver, and kidney tissue samples were collected. Levels of AST, ALT, creatinine, and oxidative stress markers including TBARS, SOD, CAT, GPx, TAS, TOS, GSH, and GSSG, along with pro-inflammatory cytokines IL-1β, IL-6, IL-8, IL-10, IL-17, and TNF-α, were measured using ELISA kits. Additionally, a histological evaluation of the tissue samples was performed. Acetaminophen causes increases in the levels of AST, ALT, creatinine, TBARS, TOS, GSSG, IL-1β, IL-6, IL-8, IL-10, IL-17, and TNF-α in serum, liver, and kidney tissue. Meanwhile, it led to a decrease in the levels of SOD, CAT, GPx, TAS, and GSH. Losartan injection reversed oxidative and inflammatory damage induced by acetaminophen. Histopathological changes in liver and kidney tissue were alleviated by losartan. The substance GW9662 increased the protective effect of losartan. In light of all the data obtained from our study, it can be said that losartan has a protective effect on liver and kidney damage induced by acetaminophen due to its antioxidant and anti-inflammatory effects. In terms of the study, losartan was found to be an alternative substance that could protect people from the harmful effects of acetaminophen.

Indexed as

AcetaminophenChemical and Drug Induced Liver InjuryKidneyLiverLosartanOxidative StressAnimalsAnti-Inflammatory AgentsAntioxidantsCytokinesKidney DiseasesMaleMiceAcetaminophenAnti-Inflammatory AgentsAntioxidantsCytokinesLosartanAcetaminophenGW9662HepatotoxicityLosartanNephrotoxicity

Identifiers

PMID38194107
PMCPMC11166798
OpenAlexW4390773806

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.